Clinical Trials
2 trialsNCT00747474 2019-11-18
Phase I Study of Intravenous LipotecanĀ® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors
Taiwan Liposome Company
Phase 1 Completed
NCT02457273 2019-04-03
Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients
National Health Research Institutes, Taiwan
Phase 2 Completed